Cargando…

Nucleolar stress controls mutant Huntington toxicity and monitors Huntington’s disease progression

Transcriptional and cellular-stress surveillance deficits are hallmarks of Huntington’s disease (HD), a fatal autosomal-dominant neurodegenerative disorder caused by a pathological expansion of CAG repeats in the Huntingtin (HTT) gene. The nucleolus, a dynamic nuclear biomolecular condensate and the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sönmez, Aynur, Mustafa, Rasem, Ryll, Salome T., Tuorto, Francesca, Wacheul, Ludivine, Ponti, Donatella, Litke, Christian, Hering, Tanja, Kojer, Kerstin, Koch, Jenniver, Pitzer, Claudia, Kirsch, Joachim, Neueder, Andreas, Kreiner, Grzegorz, Lafontaine, Denis L. J., Orth, Michael, Liss, Birgit, Parlato, Rosanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655027/ https://www.ncbi.nlm.nih.gov/pubmed/34880223 http://dx.doi.org/10.1038/s41419-021-04432-x

Ejemplares similares

Integration of the Deacetylase SIRT1 in the Response to Nucleolar Stress: Metabolic Implications for Neurodegenerative Diseases
por: Kreiner, Grzegorz, et al.
Publicado: (2019)

Targeted Depletion of Primary Cilia in Dopaminoceptive Neurons in a Preclinical Mouse Model of Huntington’s Disease
por: Mustafa, Rasem, et al.
Publicado: (2019)

Abnormal molecular signatures of inflammation, energy metabolism, and vesicle biology in human Huntington disease peripheral tissues
por: Neueder, Andreas, et al.
Publicado: (2022)

Nucleolar activity in neurodegenerative diseases: a missing piece of the puzzle?
por: Parlato, Rosanna, et al.
Publicado: (2012)

Age-at-onset in Huntington disease
por: Orth, Michael, et al.
Publicado: (2011)

Genetic mutations linked to Parkinson's disease differentially control nucleolar activity in pre-symptomatic mouse models
por: Evsyukov, Valentin, et al.
Publicado: (2017)

Observing Huntington’s Disease: the European Huntington’s Disease Network’s REGISTRY
por: Orth, Michael, et al.
Publicado: (2011)

A common gene expression signature in Huntington’s disease patient brain regions
por: Neueder, Andreas, et al.
Publicado: (2014)

Cortical neurodevelopment in pre-manifest Huntington's disease
por: Kubera, Katharina M., et al.
Publicado: (2019)

Abnormal peripheral chemokine profile in Huntington’s disease
por: Wild, Edward, et al.
Publicado: (2011)

A neuroprotective phase precedes striatal degeneration upon nucleolar stress
por: Kreiner, G, et al.
Publicado: (2013)

Dysfunction of the CNS-Heart Axis in Mouse Models of Huntington's Disease
por: Mielcarek, Michal, et al.
Publicado: (2014)

Accelerated expansion of pathogenic mitochondrial DNA heteroplasmies in Huntington’s disease
por: Wang, Yiqin, et al.
Publicado: (2021)

Silencing Srsf6 does not modulate incomplete splicing of the huntingtin gene in Huntington’s disease models
por: Mason, Michael A., et al.
Publicado: (2020)

Circulating U13 Small Nucleolar RNA as a Potential Biomarker in Huntington’s Disease: A Pilot Study
por: Romano, Silvia, et al.
Publicado: (2022)

The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington’s disease patients
por: Neueder, Andreas, et al.
Publicado: (2017)

Huntington’s Disease Pathogenesis: Two Sequential Components
por: Hong, Eun Pyo, et al.
Publicado: (2021)

Targeted Ablation of Primary Cilia in Differentiated Dopaminergic Neurons Reduces Striatal Dopamine and Responsiveness to Metabolic Stress
por: Mustafa, Rasem, et al.
Publicado: (2021)

Ribosomal transcription is regulated by PGC-1alpha and disturbed in Huntington’s disease
por: Jesse, Sarah, et al.
Publicado: (2017)

Neuropsychiatry and White Matter Microstructure in Huntington’s Disease
por: Gregory, Sarah, et al.
Publicado: (2015)

Enfermedad de Huntington
por: Muñoz García, Esteban
Publicado: (1996)

Archer Milton Huntington
por: Gilman Proske, Beatrice, 1899-
Publicado: (1963)

Neuropsychiatry of Huntington's disease
por: Rosenblatt, Adam
Publicado: (2007)

Huntington Disease in Asia
por: Xu, Miao, et al.
Publicado: (2015)

The History of Huntington's Chorea
por: Stevens, David L.
Publicado: (1972)

Irritability in Huntington’s Disease
por: Karagas, Nicholas E., et al.
Publicado: (2020)

Huntington’s and the History of Sleep
por: Wexler, Alice R.
Publicado: (2023)

Association of Huntington's disease and schizophrenia-like psychosis in a Huntington's disease pedigree
por: Corrêa, Bernardo Barahona, et al.
Publicado: (2006)

Supplemental Treatment for Huntington’s Disease with miR-132 that Is Deficient in Huntington’s Disease Brain
por: Fukuoka, Masashi, et al.
Publicado: (2018)

Absence of Acanthocytosis in Huntington’s Disease-like 2: A Prospective Comparison with Huntington’s Disease
por: Anderson, David G., et al.
Publicado: (2017)

Humanistic Burden of Huntington Disease: Evidence From the Huntington Disease Burden of Illness Study
por: Rodriguez Santana, Idaira, et al.
Publicado: (2022)

Population-specific genetic modification of Huntington's disease in Venezuela
por: Chao, Michael J., et al.
Publicado: (2018)

Mainsprings of civilization. /Huntington, Ellsworth.
por: Huntington, Ellsworth
Publicado: (1945)

Error Processing in Huntington's Disease
por: Beste, Christian, et al.
Publicado: (2006)

AMPK amplifies Huntington's disease
por: Short, Ben
Publicado: (2011)

Huntington’s Disease and Striatal Signaling
por: Roze, Emmanuel, et al.
Publicado: (2011)

Huntington's Disease: An Immune Perspective
por: Nayak, Annapurna, et al.
Publicado: (2011)

Tetrabenazine in the treatment of Huntington’s disease
por: Paleacu, Diana
Publicado: (2007)

Therapeutic Strategies in Huntington's Disease
por: Kanazawa, Ichiro
Publicado: (2006)

Neuroendocrine Disturbances in Huntington's Disease
por: Saleh, Nadine, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_udeujsinbicp4lj62ogpse07g0